The focus of Dr. Tran’s research is to identify predictive (i.e. pre-treatment) and early-response biomarkers for tumour response to chemotherapy and radiotherapy using artificial intelligence. His team is exploring quantitative imaging biomarkers from digital pathology to design computer-aided theragnostic (CAT) systems. The primary endpoint of Dr. Tran’s research will be improved patient outcomes by using biomarker measurements for adaptive and response-guided cancer treatments.